Synovial hypertrophy, not elsewhere classified, unspecified ankle and foot
ICD-10 M67.279 is a billable code used to indicate a diagnosis of synovial hypertrophy, not elsewhere classified, unspecified ankle and foot.
Synovial hypertrophy refers to the abnormal enlargement of the synovial membrane, which lines the joints and tendon sheaths. This condition can occur in various joints, including the ankle and foot, and is often associated with inflammatory processes. In the context of the ankle and foot, synovial hypertrophy may result from chronic conditions such as rheumatoid arthritis, gout, or repetitive stress injuries. Patients may present with swelling, pain, and limited range of motion in the affected joints. The diagnosis typically involves clinical examination, imaging studies such as ultrasound or MRI, and sometimes synovial fluid analysis. Treatment may include anti-inflammatory medications, physical therapy, and in some cases, surgical intervention to remove the hypertrophied tissue. Accurate coding is essential for proper management and reimbursement, as it reflects the complexity of the patient's condition and the care provided.
Detailed clinical notes on joint examination, imaging results, and treatment plans.
Patients with chronic inflammatory arthritis presenting with joint swelling.
Ensure that the underlying cause of synovial hypertrophy is documented to support the diagnosis.
Surgical notes, pre-operative assessments, and post-operative follow-ups.
Patients undergoing surgical repair of tendon ruptures associated with synovial hypertrophy.
Document any surgical interventions and their outcomes to justify coding.
Used when performing joint aspiration for diagnostic purposes.
Document the reason for aspiration and findings.
Rheumatologists often perform this procedure for synovial fluid analysis.
Synovial hypertrophy is the abnormal enlargement of the synovial membrane, often due to inflammation or irritation, leading to joint swelling and pain.
